It gives me great pleasure to announce a sponsor, BioMonde.
For the 2016 Malvern Diabetic Foot Conference, BioMonde will be sponsoring at the Bronze level.
BioMonde is a European wound care company specialising in the manufacture and distribution of larval debridement therapy products for chronic, infected and necrotic wounds.
This website is intended to provide you with information on the therapy and give answers to some of the questions that you might have about larvae.
What is Larval Therapy?
Larval Therapy, also known as ‘Maggot Therapy’ or ‘Biosurgery’ involves the use of larvae of the greenbottle fly, which are introduced into a wound to remove necrotic, sloughy and/or infected tissue. Larvae can also be used to maintain a clean wound after debridement if a particular wound is considered prone to resloughing.
The technique, which has been used for centuries, has been reintroduced into modern medicine by doctors and wound care specialists who have found that larvae are able to cleanse wounds much more rapidly than conventional dressings.